recombinant VLP-based therapeutic vaccine (VLP Biotech)

N/A

Report date: 2025/03/20 09:12:48

Base Information

Drug Namerecombinant VLP-based therapeutic vaccine (VLP Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT-cell surface antigen CD4 modulatorsCluster of differentiation 8 modulators
TargetsT-cell surface antigen CD4Cluster of differentiation 8
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVLP Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesVLP Biotech Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A